RecruitingNot ApplicableNCT05712785

Shuotongo Ureteroscopy for Upper Urinary Tract Stones

Clinical Study on the Treatment of Upper Urinary Tract Stones by Shuotong Scope

Sponsor

Handan First Hospital

Enrollment

200 participants

Start Date

Jan 1, 2020

Study Type

INTERVENTIONAL

Conditions

Urinary Calculi Ureterocele

Summary

The purpose of this study is to use the Shuotong ureteroscopy for surgical treatment of patients with upper urinary tract stones, taking advantage of the fact that the Shuotong mirror can be used for simultaneous lithotripsy and stone removal, thus maximizing the discharge of stones from the body and improving the stone removal rate.

Eligibility

Min Age: 18 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This study evaluates the Shuotongo ureteroscope — a new ureteroscopy device — for treating kidney and ureteral stones (calculi) in the upper urinary tract. Ureteroscopy is a minimally invasive procedure where a thin scope is passed through the urethra and up into the ureter or kidney to break up and remove stones. This trial assesses the safety and effectiveness of this newer device compared to standard instruments. You may be eligible if: - You have been clinically diagnosed with a ureteral or upper urinary tract stone - You are between 18 and 85 years old - You are able to cooperate with the treatment procedure You may NOT be eligible if: - You have a severe urinary tract infection - Your doctor determines you are not suitable for the study for other medical reasons Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.